34-51-1. Definitions.
Terms used in this chapter mean:
(1)"Advanced illness," any progressive disease, medical, or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of current federally approved and available treatments, and that without life sustaining procedures, would result in death;
(2)"Investigational drug, biological product, or device," any drug, biological product, or device that has successfully completed phase 1 of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in a United States Food and Drug Administration approved clinical trial;
(3)"Physician," any person who is licensed pursuant to the provisions of chapter 36-4.
Source: SL 2015, ch 188, §1.